Melanie Senior

Writer & Analyst at Nature, Evaluate, IN VIVO

Speaker

I cover biopharma R&D, strategy and investment for the Nature portfolio, Evaluate Pharma and Citeline. My work also involves panel and event moderation and supporting life sciences companies and associations.
My reporting career began at the London Financial Times. I then became Bureau Chief, Europe, for Elsevier Business Intelligence (subsequently Informa), worked on US reimbursement and pricing with Real Endpoints and was part of EY Life Sciences’ thought leadership team (2014-2017).
I have a First Class degree in Natural Sciences (biochemistry) from Cambridge University and post-graduate qualifications in Sports Physiology & Nutrition (St Mary’s University) and in International Health Technology Assessment (University of Sheffield).
I’m a keen runner, cyclist and swimmer and am based in London, UK.